Unilateral Heliotrope rash in Anti‐MDA5 dermatomyositis. Two Case Reports and Review of the Literature
Dr. Mascaró reports serving as a clinical trial investigator for Astra Zeneca, Argenx BV, and Principia Biopharma, Sanofi; receiving speaker fees from ADIMYF, Astra Zeneca, Bocentium Consulting SL, Fundacio Clinic Per La Recerca, Fundació Institut de Recerca Hospital de la Santa Creu i Sant Pau, Fundacion Piel Sana de la AEDV, Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular, International School of Derma SL, Janssen, Laboratorios Viñas, MFAR - Marketing Farmacéutico, Organon Salud, Sanofi-Aventis, Viatris Pharmaceuticals SL; and serving as an editorial board member for the journals Actas Dermo-Sifiliográficas, and Dermatopathology, all outside the submitted work.
Authors
- Berta Ferrer-Rosell (ORCID: https://orcid.org/0000-0001-5554-0782)
- Priscila Giavedoni (ORCID: https://orcid.org/0000-0002-1474-9261)
- José M. Mascaró (ORCID: https://orcid.org/0000-0001-9327-2555)
- José C. Milisenda (ORCID: https://orcid.org/0000-0003-0151-7872)
- Adriana García‐Herrera (ORCID: https://orcid.org/0000-0003-4156-1587)
- Javier Gil‐Lianes (ORCID: https://orcid.org/0000-0001-7235-528X)
Institutions
- Hospital Clínic de Barcelona (ES)
- Vall d'Hebron Hospital Universitari (ES)
Publication Details
- Journal
- JDDG Journal der Deutschen Dermatologischen Gesellschaft
- Published
- 2025-10-18
- DOI
- https://doi.org/10.1111/ddg.15946
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00